摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(3-氨基苯基)烟酰胺 | 63556-12-7

中文名称
N-(3-氨基苯基)烟酰胺
中文别名
——
英文名称
N-(3-aminophenyl)nicotinamide
英文别名
N-(3-aminophenyl)pyridine-3-carboxamide
N-(3-氨基苯基)烟酰胺化学式
CAS
63556-12-7
化学式
C12H11N3O
mdl
MFCD09045986
分子量
213.239
InChiKey
AOFYAWXZEPQFIW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    68
  • 氢给体数:
    2
  • 氢受体数:
    3

安全信息

  • 危险等级:
    IRRITANT
  • 海关编码:
    2933399090

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-(3-氨基苯基)烟酰胺苯甲酰氯三乙胺 作用下, 以 乙腈 为溶剂, 反应 5.0h, 生成 N-(3-benzamidophenyl)pyridine-3-carboxamide
    参考文献:
    名称:
    Potent and selective inhibitors of the TASK-1 potassium channel through chemical optimization of a bis-amide scaffold
    摘要:
    TASK-1 is a two-pore domain potassium channel that is important to modulating cell excitability, most notably in the context of neuronal pathways. In order to leverage TASK-1 for therapeutic benefit, its physiological role needs better characterization; however, designing selective inhibitors that avoid the closely related TASK-3 channel has been challenging. In this study, a series of bis-amide derived compounds were found to demonstrate improved TASK-1 selectivity over TASK-3 compared to reported inhibitors. Optimization of a marginally selective hit led to analog 35 which displays a TASK-1 IC50=16 nM with 62-fold selectivity over TASK-3 in an orthogonal electrophysiology assay.
    DOI:
    10.1016/j.bmcl.2014.06.032
  • 作为产物:
    描述:
    烟酰氯 在 sodium tetrahydroborate 、 三乙胺 作用下, 以 甲醇二氯甲烷乙腈 为溶剂, 反应 6.0h, 生成 N-(3-氨基苯基)烟酰胺
    参考文献:
    名称:
    Potent and selective inhibitors of the TASK-1 potassium channel through chemical optimization of a bis-amide scaffold
    摘要:
    TASK-1 is a two-pore domain potassium channel that is important to modulating cell excitability, most notably in the context of neuronal pathways. In order to leverage TASK-1 for therapeutic benefit, its physiological role needs better characterization; however, designing selective inhibitors that avoid the closely related TASK-3 channel has been challenging. In this study, a series of bis-amide derived compounds were found to demonstrate improved TASK-1 selectivity over TASK-3 compared to reported inhibitors. Optimization of a marginally selective hit led to analog 35 which displays a TASK-1 IC50=16 nM with 62-fold selectivity over TASK-3 in an orthogonal electrophysiology assay.
    DOI:
    10.1016/j.bmcl.2014.06.032
点击查看最新优质反应信息

文献信息

  • Diastereoselectively self-sorted low-symmetry binuclear metallomacrocycle and trinuclear metallocage
    作者:Srabani Srotoswini Mishra、Dillip Kumar Chand
    DOI:10.1039/d2dt01571d
    日期:——
    arrangement. However, one of the isomers of the Pd2L′2Lun2-type complex as well as the one for the Pd3Lun6-type complex are experimentally obtained. The exclusive formation of specific isomers could be predicted from the 1D/2D NMR study in the solution state and the DFT calculations in the gas phase/implicit solvent media. The formation of the predicted all-(1,1)-[Pd2(en)2Lun2](NO3)4 has been confirmed
    通过烟酸与过量间苯二胺的缩合合成吡啶/苯胺附加的不对称双单齿配体N- (3-氨基苯基)烟酰胺,L un 。Pd 2 L' 2 L un 2型的低对称双核配合物和Pd 3 L un 6型的极为罕见的三核配合物是由配体L un与顺式保护的钯( II )自组装产生的(即,PdL')和钯(II),分别。两种异构体(即[(2,0), (2,0)] 和 [(1,1), (1,1)]-形式) 理论上可能用于 Pd 2 L' 2 L un 2型配合物,而九种异构体可以在 Pd 3 L un 6型排列的情况下可以设想。然而,Pd 2 L' 2 L un 2型络合物的异构体之一以及Pd 3 L un 6的异构体型复合物是通过实验获得的。可以通过溶液状态下的 1D/2D NMR 研究和气相/隐式溶剂介质中的 DFT 计算来预测特定异构体的排他性形成。预测的全-(1,1)-[Pd 2 (en) 2 L un 2 ](NO
  • Neighboring Cage Participation for Assisted Construction of Self-Assembled Multicavity Conjoined Cages and Augmented Guest Binding
    作者:Srabani S. Mishra、Shobhana Krishnaswamy、Dillip Kumar Chand
    DOI:10.1021/jacs.3c10565
    日期:2024.2.21
    smaller one binds a nitrate, fluoride, chloride, or bromide. The Pd4L4 cage, having a central bigger Pd2L4 cavity and two smaller peripheral Pd2L4 cavities, binds one PZDO and two nitrate, fluoride, chloride, or bromide. The smaller cavity can be prepared individually from Pd(II) and bis-monodentate ligand (L4), however, in the presence of template like a nitrate, fluoride, chloride, or bromide; otherwise
    通过 Pd(NO 3 ) 2与设计的双单齿 ( L1 ) 络合制备了一组 Pd 2 L 4 、 Pd 3 L 4和 Pd 4 L 4型单腔、双腔和三腔笼。 、三单齿 ( L2 ) 和四单齿 ( L3 ) 配体。 Pd 2 L 4笼与Pd 3 L 6笼处于平衡状态;在 70 °C 或添加吡嗪-N,N'-二氧化物 (PZDO) 时,平衡转移至 Pd 2 L 4 。 Pd 2 L 4笼利用静电、分叉氢键和过度协调氢键相互作用结合PZDO分子。离散的Pd 3 L 4和Pd 4 L 4化合物是由不等尺寸的Pd 2 L 4笼(较大和较小)组成的连体笼。 Pd 3 L 4笼的较大单元选择性地结合PZDO,较小的单元结合硝酸盐、氟化物、氯化物或溴化物。 Pd 4 L 4笼具有一个较大的中央Pd 2 L 4空腔和两个较小的外围Pd 2 L 4空腔,结合一个PZDO和两个硝酸盐、氟化物、氯化物或溴化物。较小的空腔可以单独由
  • US3966706A
    申请人:——
    公开号:US3966706A
    公开(公告)日:1976-06-29
  • Potent and selective inhibitors of the TASK-1 potassium channel through chemical optimization of a bis-amide scaffold
    作者:Daniel P. Flaherty、Denise S. Simpson、Melissa Miller、Brooks E. Maki、Beiyan Zou、Jie Shi、Meng Wu、Owen B. McManus、Jeffrey Aubé、Min Li、Jennifer E. Golden
    DOI:10.1016/j.bmcl.2014.06.032
    日期:2014.8
    TASK-1 is a two-pore domain potassium channel that is important to modulating cell excitability, most notably in the context of neuronal pathways. In order to leverage TASK-1 for therapeutic benefit, its physiological role needs better characterization; however, designing selective inhibitors that avoid the closely related TASK-3 channel has been challenging. In this study, a series of bis-amide derived compounds were found to demonstrate improved TASK-1 selectivity over TASK-3 compared to reported inhibitors. Optimization of a marginally selective hit led to analog 35 which displays a TASK-1 IC50=16 nM with 62-fold selectivity over TASK-3 in an orthogonal electrophysiology assay.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐